from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3830c/-

LFCtreatmentdescriptionclass of inhibitor

-1.324

Amikacinug/mL Amikacintranslation

-0.328

Cap5-10ug/mL Capreomycintranslation

0.232

Rox10-50 ug/mL Roxithromycintranslation

-0.907

SM2-5 ug/mL Streptomycintranslation

-0.639

Tet5-10 ug/mL Tetracyclinetranslation

0.152

Rif0.2-5ug/mL Rifampicintranscription

-0.916

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.732

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.404

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.037

CPZ10-50 ug/mL Chlorpromazinerespiration

0.924

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.321

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.330

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.952

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.089

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.219

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.369

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.242

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.216

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.635

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.459

KCN5-20 ug/mL Potassium cyaniderespiration

-1.154

NaN30.2-2 mM Sodium aziderespiration

-0.129

Nigericin50 uM Nigericinrespiration

0.484

TRC10-150 ug/mL Triclosanrespiration

1.295

TRZ10-25 ug/mL Thioridazinerespiration

0.532

Valinomycin0.5-10 uM Valinomycinrespiration

-1.024

ZnSO42 mM ZnSO4respiration

0.966

menadione6-10 ug/mL Menadionerespiration

-0.286

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.536

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.315

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.364

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.322

NRP_1Non-replicating persistence stage 1dosRassociated

-0.185

Amp0.2mg/mL AmpicillincellWall

-0.016

Cephalexin20-100 ug/mL CephalexincellWall

-0.545

Cerulenin0.32-5 ug/mL CerulenincellWall

0.178

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.607

EMB10-20 ug/mL EthambutolcellWall

-1.182

Eta12-40 ug/mL EthionamidecellWall

-1.552

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.884

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.690

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.851

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.164

BZA0.12 mg/mL BenzamidearomaticAmides

0.240

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.049

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.330

H2O24 mM hydrogen peroxideDNAdamaging

-0.916

Levo10 ug/mL LevofloxacinDNAdamaging

0.473

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.958

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.178

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.375

UVUV-irradiationDNAdamaging

2.088

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.762

Antimycin12.5-50 ug/mL Antimycin A?

0.176

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.032

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.744

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.144

PA8240.2-2 ug/mL PA-824?

-0.186

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.246

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.292

Verapamil50 uM Verapamil?

0.171

mercaptoethanol2 mM 2-Mercaptoethanol?

0.020

methoxatin10-20 ug/mL Methoxatin?